Blood-Dervived Thearpy

Overview

This therapy is purely Blood-Derived and minimally invasive.  Follow-up treatments may need to be performed more often for optimal results.

Blood-Derived Therapy

The Blood-Derived Therapy is performed in a clinical outpatient setting over the course of two days. After the Lung Institute’s medical staff has determined that a patient is a candidate for treatment, he or she will be asked to fill out all of the required paper work. A pulmonary function test will be performed, and the patient will go through a preparation process. Following the insertion of an IV, the blood cells are harvested, processed and separated and then immediately returned to the patient’s body intravenously where they may promote healing. This process is also repeated on day two of the patient’s treatment program. This minimally invasive procedure has proven to be a viable option for many patients with chronic obstructive pulmonary disease (COPD). At the end of day two, the overseeing physician will do a thorough evaluation of the patient’s treatment and prep him or her for follow-up care.

Follow-Up Care

The patient will receive follow up care at the two-week, three-month and six-month mark following his or her treatment. The patient is encouraged to return for a follow-up appointment with his or her pulmonologist at the three-month mark.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

linus

 

Linus S. | Hays, KS | COPD Blood-Derived Therapy

“3 months after my treatment, I was working in a 2 story building with 26 stairs. I noticed one day that when I got to the top of the stairs, I didn’t have to stop and use my inhaler.”

Related Posts

  • Avocados are great sources of folate, which has been shown to have a positive correlation with lung function in COPD patients, as well as lung-healthy vitamin B6. Make sure to ... Read more
  • Sarcoidosis of the lungs results from the growth of granulomas, or inflammatory cells, and is characterized by a persistent dry cough, shortness of breath, wheezing and chest pain. While sarcoidosis ... Read more

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.